Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Avinash Jain (Varanasi, India), Avinash Jain, S.K. Agrawal. Significance of quantitative radiological phenotypes of COPD on BODE index. Eur Respir J 2016; 48: Suppl. 60, 4175

Member's Comments

No comment yet.

Related content which might interest you: Clinical and inflammatory characteristics of 'unreported' COPD exacerbations Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Evaluation of the GOLD 2011 severity criteria across the COPD spectrum Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Symptom profile of exacerbations in earlier and later COPD Source: Annual Congress 2013 –Asthma and COPD: diseases with different phenotypes Year: 2013 COPD staging systems and BODE index Source: International Congress 2016 – Non-inflammatory assessment of airway disorders Year: 2016 Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014 Early phenotypes of chronic obstructive pulmonary disease (COPD) Source: International Congress 2015 – Different data in COPD Year: 2015 Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015 GOLD and phenotypes: The new Czech COPD guidelines Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections Year: 2015 Does the 2011 GOLD staging of COPD reflect phenotype and severity of the disease as assessed by CT? Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Gender differences in COPD patients Source: International Congress 2014 – Clinical presentations Year: 2014 The clinical significance and frequency of bronchiectasis in COPD patients Source: International Congress 2016 – Monitoring comorbidities Year: 2016 CAT in COPD phenotypes (POPE study) Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Statistical analysis of anthropometric differences between COPD stages 1 and 2 Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016 COPD on anti-GERD therapy remains at higher risk for severe exacerbation Source: International Congress 2014 – COPD exacerbations Year: 2014 The prognostic value of cardiac and inflammatory biomarkers in acute exacerbations of COPD Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016 The distribution of phenotypes in a population of severe COPD Source: International Congress 2014 – COPD exacerbations Year: 2014 Role of inflammatory biomarkers in COPD Source: International Congress 2016 – Systemic biomarkers Year: 2016